Andrés Carevic

Babyscripts Welcomes New Board of Directors Member Katerina Fialkovskaya

Retrieved on:

Tuesday, August 8, 2023

Venture capital, Health, Woman, MBA, MIT, Female, M&A, Investment, MassChallenge, ACCA, Obstetrics, Andrés Carevic, Management, Nursing, Orbit (anatomy)

WASHINGTON, Aug. 8, 2023 /PRNewswire-PRWeb/ -- Babyscripts, the leading virtual care platform for managing obstetrics, today announced that Katerina Fialkovskaya, leader of corporate venture investments for Philips Ventures in North America, is joining the Babyscripts Board of Directors. In this role, Ms. Fialkovskaya will advise on Babyscripts' operations in the payer market and strategic product expansion for high risk populations.

Key Points:

Fialkovskaya to advise on product strategy, payer expansion; reflects Babyscripts' commitment to female leadership
WASHINGTON, Aug. 8, 2023 /PRNewswire-PRWeb/ -- Babyscripts , the leading virtual care platform for managing obstetrics, today announced that Katerina Fialkovskaya, leader of corporate venture investments for Philips Ventures in North America, is joining the Babyscripts Board of Directors.
In this role, Ms. Fialkovskaya will advise on Babyscripts' operations in the payer market and strategic product expansion for high risk populations.
Ms. Fialkovskaya brings extensive experience to the Babyscripts' Board of Directors, serving as Board Director or Board Observer at several startups including MOVN Health, Orbita, PreciseDx, and Carevive.
"We are thrilled to welcome Katerina to our Board of Directors," said Anish Sebastian, CEO of Babyscripts.

Carevive Launches Native App Technology for the Carevive PROmpt® Patient Engagement Platform

Retrieved on:

Wednesday, March 1, 2023

Human, Breast cancer, Cancer, Diagnosis, Touch ID, Pain, Collection, Patient satisfaction, Android, Patient, Reading, Face ID, Health, Prompt, Apple, Communication, Medical device, Nursing, Andrés Carevic

BOSTON, March 1, 2023 /PRNewswire/ -- Carevive Systems ("Carevive") the leading oncology-focused health technology company is centered on understanding and improving the experience of patients with cancer using their unique Patient-Reported Outcomes Mobile Platform (PROmpt). Carevive PROmpt® enables cancer patients to report new symptoms and receive valuable information about their treatment while at the same time providing clinicians a way to monitor their patients' health and address impediments to treatment success remotely.

Key Points:

Carevive PROmpt® Native App Technology enhances remote patient monitoring and reduces patient adoption barriers.
BOSTON, March 1, 2023 /PRNewswire/ -- Carevive Systems ("Carevive") the leading oncology-focused health technology company is centered on understanding and improving the experience of patients with cancer using their unique Patient-Reported Outcomes Mobile Platform ( PROmpt ).
"Having a native mobile app option increases accessibility and usability which means patients are more likely to respond, leading to better outcomes and increased patient satisfaction."
With regards to downloading and using the new Carevive PROmpt® native app, one 65-year-old breast cancer patient in Montana adds, "I installed the [Carevive PROmpt®] app and it was smooth sailing from there, wish I had the app in the beginning.

Leading Oncology Patient-Reported Outcomes Technology Company Launches Commercialization of Computerized Cancer Symptom Management Pathways

Retrieved on:

Thursday, February 16, 2023

Patient satisfaction, NCI, Assessment, Data, Ampere-hour, National Cancer Institute (Egypt), RN, Charleston Area Medical Center, Patient, Triage, Research, Rapid response system, EHR, Nursing, Intervention, BSN, Cancer Breakthroughs 2020, Pharmaceutical industry, Andrés Carevic

BOSTON, Feb. 16, 2023 /PRNewswire/ -- Carevive Systems, Inc., a leading innovator in cancer care management software with a deep real-world evidence patient dataset, announced today that it will launch the commercialization of its computerized cancer symptom management pathways. These pathways were developed through the generous support of a multi-million dollar Phase I/II Small Business Innovations Research contract funded by the National Cancer Institute. This product took over five years to develop, test, and pilot with input from an international panel of cancer symptom experts. Phase I was awarded by the NCI in 2018, and Phase II in 2020. Symptom management is a focus of the Cancer Moonshot Initiative (https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiati...). Carevive is the only company that applied for and received a Fast-Track Phase I/II contract award from the NCI under this research topic. Carevive STAIRS™ (Symptom Triage, Assessment, Intervention and Response System) initially covers the eight most common cancer symptoms which, when severe, result in treatment interruptions, modifications, or discontinuations and hospitalizations.

Key Points:

First-ever commercialized cancer symptom management pathways, Carevive STAIRS™, will reduce hospitalizations and improve cancer clinic processes.
BOSTON, Feb. 16, 2023 /PRNewswire/ -- Carevive Systems, Inc., a leading innovator in cancer care management software with a deep real-world evidence patient dataset, announced today that it will launch the commercialization of its computerized cancer symptom management pathways.
This product took over five years to develop, test, and pilot with input from an international panel of cancer symptom experts.
Company launches first-ever commercialized cancer symptom management pathways, Carevive STAIRS.

Cancer Support Community Addresses Elevated Need for Mental Healthcare with New Mental Health Programs and Initiatives

Retrieved on:

Monday, January 23, 2023

These come at a time when the need for mental health care is at an all-time high.

Key Points:

These come at a time when the need for mental health care is at an all-time high.
According to the National Institute of Mental Health, nearly 1 in 5 adults in the United States live with a mental illness.
“At CSC, we understand that mental health care and psychosocial support are crucial to whole-person cancer care,” said Alexandra Zaleta, Ph.D., CSC’s Vice President of Research.
The study was funded by BeiGene, who used the learnings to help develop Talk About It, its new mental health support website for cancer patients.

Carrie Tompkins Stricker, PhD, RN, ANP-BC, CRNP, Receives APSHO Award for Excellence in Oncology Advanced Practice

Retrieved on:

Wednesday, November 9, 2022

LAWRENCEVILLE, N.J., Nov. 9, 2022 /PRNewswire-PRWeb/ -- The Advanced Practitioner Society for Hematology and Oncology (APSHO) presented the fifth annual Mary Pazdur Award for Excellence in Advanced Practice in Oncology to Carrie Tompkins Stricker, PhD, RN, ANP-BC, CRNP, an associate professor at Thomas Jefferson University College of Nursing. Created in honor of the late Mary Pazdur, RN, MSN, the award is presented to an advanced practitioner and member of APSHO who consistently demonstrates exemplary leadership and outstanding contributions to clinical practice, research, and education in the oncology/hematology field.

Key Points:

The award recognizes an exceptional leader, mentor, and champion of advanced practice in oncology/hematology.
LAWRENCEVILLE, N.J., Nov. 9, 2022 /PRNewswire-PRWeb/ -- The Advanced Practitioner Society for Hematology and Oncology (APSHO) presented the fifth annual Mary Pazdur Award for Excellence in Advanced Practice in Oncology to Carrie Tompkins Stricker, PhD, RN, ANP-BC, CRNP, an associate professor at Thomas Jefferson University College of Nursing.
The award ceremony took place during JADPRO Live, an annual educational event during which the APSHO annual meeting takes place.
The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society of nearly 4,000 oncology advanced practitioners, including nurse practitioners, physician assistants, pharmacists, clinical nurse specialists, and other health-care professionals.

Cancer Support Community and Carevive Partner on Innovative Care Delivery Model

Retrieved on:

Thursday, August 11, 2022

WASHINGTON, D.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC) and Carevive are partnering to provide an innovative nursing and social work team-based care delivery model to health systems across the U.S.

Key Points:

WASHINGTON, D.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC) and Carevive are partnering to provide an innovative nursing and social work team-based care delivery model to health systems across the U.S.
PROmpt cancer care management is a cancer care management technology used for treatment and survivorship care planning, and symptom monitoring and management used to improve the treatment experience of patients with cancer and improve survival outcomes, while lowering costs.
Carevive has licensed cancer care management technology to over 50 cancer centers across the U.S. over the past decade.
The proactive and innovative model addresses numerous shortfalls in current cancer care delivery and keeps a real-life cancer care team engaged with patients while at home.

Carevive Partners with Datavant to Connect Carevive SMART Data™ and Advance Life Science Research

Retrieved on:

Thursday, March 31, 2022

Drug development, Organization, SMART, Health information management, Privacy, Cancer, CEO, Quality of life, Health, Friction, GLOBE, SAN, Patient, Pros, Medicine, Pharmaceutical industry, Andrés Carevic

Carevive has captured over 150,000 data points across five major cancers and weekly surveys have an 85-90% completion rate.

Key Points:

Carevive has captured over 150,000 data points across five major cancers and weekly surveys have an 85-90% completion rate.
Datavant will enable Carevive to de-identify and connect patient experience data to other sources such as electronic health records, payor claims, diagnostics, and consumer household panels in order to provide enriched insights into the holistic patient experience.
Monitoring patients remotely has helped our clinician partners better understand and support patients through their care journey, noted Bruno Lempernesse, CEO of Carevive.
With Datavant we can offer life sciences companies a rich understanding of patients' symptoms, activity levels, and a variety of quality of life measures and connect these data to other real-world data for an unparalleled understanding of cancer patients' experiences with new therapies.

Carevive Appoints Aaron Galaznik, M.D. as Chief Scientific Officer

Retrieved on:

Tuesday, February 15, 2022

Carevive Systems (Carevive) the leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer, today announced that it has appointed Aaron Galaznik, M.D.

Key Points:

Carevive Systems (Carevive) the leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer, today announced that it has appointed Aaron Galaznik, M.D.
In this new role, Dr. Galaznik will lead all scientific and clinical activities associated with Carevive, including its real-world evidence (RWE) and patient reported outcomes (PRO) strategies.
Dr. Galaznik brings more than 15 years of experience in real-world data and analytics to Carevive.
We are excited to welcome Aaron to the Carevive family, someone I have had the pleasure of working with previously, said Bruno Lempernesse, Chief Executive Officer of Carevive.